Abbott Laboratories (ABT) Asset Writedowns and Impairment (2016)
Abbott Laboratories (ABT) posted Asset Writedowns and Impairment of $947.0 million for Q3 2016.
Abbott Laboratories (ABT) Asset Writedowns and Impairment (2016) Analysis & Trends
Abbott Laboratories has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $947.0 million in Q3 2016.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $947.0 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $947.0 million (changed N/A YoY) and the FY2016 annual result came in at $947.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was little changed at $947.0 million in Q3 2016 per ABT's latest filing.
- Over five years, Asset Writedowns and Impairment peaked at $947.0 million in Q3 2016 and troughed at $947.0 million in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 947.00 Mn |
| Sep 30, 2016 | 947.00 Mn |